| 2022-01-05 | Sale | Keros Therapeutics, Inc. KROS | director | 4,034 0.0174% | $58.25 | $234,991 | -18.81% | |
| 2022-01-04 | Sale | Keros Therapeutics, Inc. KROS | director | 20,062 0.082% | $57.55 | $1.15M | -21.81% | |
| 2022-01-03 | Sale | Keros Therapeutics, Inc. KROS | director | 23,555 0.0959% | $58.01 | $1.37M | -22.56% | |
| 2021-12-02 | Sale | Keros Therapeutics, Inc. KROS | director | 25,338 0.1068% | $53.57 | $1.36M | -14.99% | |
| 2021-12-01 | Sale | Keros Therapeutics, Inc. KROS | director | 22,313 0.0981% | $54.68 | $1.22M | -13.08% | |
| 2021-11-03 | Sale | Keros Therapeutics, Inc. KROS | director | 15,967 0.0688% | $41.95 | $669,780 | +12.71% | |
| 2021-11-02 | Sale | Keros Therapeutics, Inc. KROS | director | 7,881 0.0337% | $42.40 | $334,149 | +10.47% | |
| 2021-11-01 | Sale | Keros Therapeutics, Inc. KROS | director | 23,803 0.1% | $42.15 | $1M | +8.8% | |
| 2021-10-20 | Sale | Keros Therapeutics, Inc. KROS | director | 4,082 0.0175% | $38.24 | $156,095 | +20.78% | |
| 2021-10-19 | Sale | Keros Therapeutics, Inc. KROS | director | 4,516 0.0193% | $38.16 | $172,346 | +20.91% | |
| 2021-10-18 | Sale | Keros Therapeutics, Inc. KROS | director | 13,786 0.0586% | $37.70 | $519,711 | +21.74% | |
| 2021-10-15 | Sale | Keros Therapeutics, Inc. KROS | director | 8,198 0.0351% | $39.16 | $321,052 | +17.95% | |
| 2021-10-14 | Sale | Keros Therapeutics, Inc. KROS | director | 4,383 0.0188% | $40.13 | $175,890 | +15.36% | |
| 2021-10-05 | Sale | Keros Therapeutics, Inc. KROS | director | 2,617 0.0112% | $40.03 | $104,759 | +13.06% | |
| 2021-10-04 | Sale | Keros Therapeutics, Inc. KROS | director | 3,746 0.0163% | $40.06 | $150,065 | +14.46% | |
| 2021-10-01 | Sale | Keros Therapeutics, Inc. KROS | director | 6,323 0.0271% | $40.16 | $253,932 | +15.23% | |
| 2021-09-27 | Sale | Keros Therapeutics, Inc. KROS | director | 95,302 0.3843% | $41.17 | $3.92M | +3.02% | |
| 2021-07-02 | Sale | Keros Therapeutics, Inc. KROS | director | 23,818 0.1028% | $41.34 | $984,565 | +12.2% | |
| 2021-07-01 | Sale | Keros Therapeutics, Inc. KROS | director | 23,834 0.1022% | $41.28 | $983,787 | +9.24% | |
| 2021-06-07 | Sale | Keros Therapeutics, Inc. KROS | director | 12,796 0.0542% | $49.89 | $638,451 | -5.79% |